Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

ANGLE signs commercial agreement with AstraZeneca

April 26, 2024
Business Services Angle, AstraZeneca, Pharmacy, commercial agreement

ANGLE has announced that it has signed a supplier agreement with AstraZeneca for the development and validation of a methodology …

News

AstraZeneca shares results for Imfinzi in phase 3 trial for small cell lung cancer

April 5, 2024
Research and Development AstraZeneca, Imfinzi, Oncology, clinical trial, lung cancer

AstraZeneca has announced positive high-level results from the phase 3 ADRIATIC trial, which demonstrated that Imfinzi (durvalumab) had a statistically …

News

FDA accepts BLA for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for breast cancer treatment

April 2, 2024
Research and Development AstraZeneca, Daiichi Sankyo, FDA, Oncology, bla, breast cancer

AstraZeneca and Daiichi Sankyo have announced that their Biologics License Application (BLA) for datopotamab deruxtecan (Dato-Dxd) has been accepted in …

News

FDA approves AstraZeneca’s Ultomiris for NMOSD treatment

March 25, 2024
Medical Communications AstraZeneca, FDA, Neurology, Ultomiris, neuromyelitis optica spectrum disorder

AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvs) as the first and only …

News

AstraZeneca to acquire Fusion for approximately $2bn

March 19, 2024
Business Services AstraZeneca, Fusion Pharmaceuticals, Oncology, acquisition, radioconjugates

AstraZeneca has announced that it has entered into a definitive agreement to acquire Fusion Pharmaceuticals for an approximate $2bn. This …

News

AstraZeneca to acquire Amolyt Pharma for up to $1.05bn

March 14, 2024
Business Services Amolyt Pharma, AstraZeneca, Rare Diseases, acquisition, rare diseases

AstraZeneca has announced that it has entered into a definitive agreement under which it will acquire Amolyt Pharma for up …

News

AstraZeneca’s Voydeya recommended for approval in EU by CHMP

February 29, 2024
Medical Communications AstraZeneca, CHMP, EMA, Haematology, Voydeya

AstraZeneca has announced that Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) by the Committee …

News

AstraZeneca’s Tagrisso approved by FDA for lung cancer treatment

February 19, 2024
Medical Communications AstraZeneca, Oncology, Tagrisso, lung cancer

AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Tagrisso for the treatment of adult patients …

News

AstraZeneca shares results from phase 3 trial of acoramidis in adults with ATTR-CM

February 2, 2024
Research and Development ATTR-CM, AstraZeneca, Cardiology, acoramidis, clinical trial

AstraZeneca has announced positive high-level results from the phase 3 trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) …

News
anirudh-djo3injpaoe-unsplash_3

AstraZeneca’s Voydeya approved in Japan for PNH treatment

January 19, 2024
Medical Communications AstraZeneca, Haematology, PNH, Voydeya

AstraZeneca has announced that Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal haemoglobinuria (PNH), in …

News

C4X receives $11m milestone payment from AstraZeneca

January 3, 2024
Sales and Marketing AstraZeneca, C4X, C4X Discovery, Chronic Diseases

C4X Discovery Holdings has announced that it has received a milestone payment of $11m from AstraZeneca which has been triggered …

News

AstraZeneca and Sanofi’s Beyfortus approved in China

January 2, 2024
Research and Development AstraZeneca, Beyfortus, China, Immunology, Sanofi

AstraZeneca and Sanofi have announced that Beyfortus (nirsevimab) has been approved in China for the prevention of respiratory syncytial virus …

News

FDA approves AstraZeneca and Ionis’s Wainua

December 22, 2023
Medical Communications AstraZeneca, FDA, Ionis, Neurology, Wainua

AstraZeneca and Ionis have announced that the US Food and Drug Administration (FDA) has approved Wainua (eplontersen) for the treatment …

News

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023
Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …

News
carlos-muza-hpjsku2uysu-unsplash_1

AstraZeneca launches health-tech business, Evinova

November 21, 2023
Business Services AstraZeneca, Pharmacy, health-tech

AstraZeneca has announced that it has launched Evinova, its new health-tech business, which it is hoped will become a leading …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026